ArticleFrontiers in oncology2022

Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN.

Xi Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.